Dare Bioscience Inc DARE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:54 PM EDT
0.44quote price arrow up+0.0051 (+1.173%)
Volume
15,916
Close
0.4348quote price arrow up+0.0748 (+20.7778%)
Volume
855,610
52 week range
0.27 - 1.06
Loading...
  • Open0.40
  • Day High0.4499
  • Day Low0.37
  • Prev Close0.36
  • 52 Week High1.06
  • 52 Week High Date05/16/23
  • 52 Week Low0.27
  • 52 Week Low Date12/08/23

Key Stats

  • Market Cap43.733M
  • Shares Out100.58M
  • 10 Day Average Volume0.51M
  • Dividend-
  • Dividend Yield-
  • Beta1.32
  • YTD % Change40.71

KEY STATS

  • Open0.40
  • Day High0.4499
  • Day Low0.37
  • Prev Close0.36
  • 52 Week High1.06
  • 52 Week High Date05/16/23
  • 52 Week Low0.27
  • 52 Week Low Date12/08/23
  • Market Cap43.733M
  • Shares Out100.58M
  • 10 Day Average Volume0.51M
  • Dividend-
  • Dividend Yield-
  • Beta1.32
  • YTD % Change40.71

RATIOS/PROFITABILITY

  • EPS (TTM)-0.32
  • P/E (TTM)-1.37
  • Fwd P/E (NTM)-3.72
  • EBITDA (TTM)-30.902M
  • ROE (TTM)-994.69%
  • Revenue (TTM)2.808M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-1,074.17%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Dare Bioscience Inc

 

Profile

MORE
Dare Bioscience, Inc. is a biopharmaceutical company committed to advancing products for women's health. XACIATO, the Company's United States Food and Drug Administration (FDA)-approved product, vaginal gel 2%, a lincosamide antibacterial indicated for the treatment of bacterial vaginosis in female patients 12 years of age and older, which is under a global license agreement with Organon. Its clinical-stage programs include Ovaprene; Sildenafil Cream, 3.6%; DARE-HRT1;...
William Rastetter Ph.D.
Independent Chairman of the Board
Sabrina Johnson
President, Chief Executive Officer, Principal Financial Officer, Company Secretary, Director
Address
3655 Nobel Dr Ste 260
San Diego, CA
92122-1050
United States

Top Peers

SYMBOLLASTCHG%CHG
SPRB
Spruce Biosciences Inc
0.7699-0.0301-3.7625%
BOLT
Bolt Biotherapeutics Inc
0.8251-0.0049-0.5904%
MRKR
Marker Therapeutics Inc
4.06-0.11-2.64%
ALGS
Aligos Therapeutics Inc
0.655-0.0241-3.5488%
SQZB
SQZ Biotechnologies Co
0.021UNCHUNCH